Oblong, Inc.
OBLGOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4M | $2.4M | $3.8M | $5.5M | $7.7M | $15.3M |
| Operating income | −$3.0M | −$4.2M | −$4.5M | −$22.0M | −$11.8M | −$10.1M |
| Net income | −$6.4M | −$4.0M | −$4.4M | −$21.9M | −$9.1M | −$7.4M |
| Total assets | $8.2M | $5.3M | $6.9M | $5.7M | $28.6M | $29.1M |
| Total liabilities | $1.2M | $1.3M | $1.4M | $2.0M | $3.1M | $7.1M |
| Equity | $7.0M | $4.0M | $5.5M | $3.6M | $25.5M | $22.1M |
| EPS (diluted) | $-2.76 | $-15.71 | $-0.98 | $-10.62 | $-5.48 | $-1.48 |
| Shares out. | 1.2M | 16.7M | 2.1M | 30.8M | 26.6M | 5.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −121.5%
- Net margin
- −260.8%
- Return on equity
- −90.4%
- Return on assets
- −77.3%
- Return on capital (ROCE)
- −42.1%
- Liabilities / assets
- 14.4%
- Debt / equity
- 0.17×
- Book value / share
- $6.09
- Revenue growth (YoY)
- 2.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -85.24distress
- Accruals / assets
- −40.6%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗May 15, 2020
- NT 10-Kmissed a reporting deadline ↗Apr 3, 2006
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Holst PeterOfficer — President and CEO | Nov 19, 2025 | Buy | 5,000 | $1.90 |
| Holst PeterOfficer — President and CEO | Nov 14, 2025 | Buy | 10,000 | $1.84 |
| Schechter JonathanDirector | Nov 14, 2025 | Buy | 10,000 | $1.91 |
| Schechter JonathanDirector | Sep 17, 2025 | Buy | 5,000 | $2.70 |
| Schechter JonathanDirector | Sep 16, 2025 | Buy | 10,000 | $2.73 |
| Adelman Jason TDirector | Sep 4, 2025 | Buy | 1,000 | $2.62 |
| Adelman Jason TDirector | Oct 24, 2023 | Sell | 52,191 | $0.18 |
| Foundry Group Select Fund, L.P.10% owner | Jul 3, 2023 | J | 85,017 | — |
| Meredith Deborah JeanDirector | Jun 16, 2023 | Sell | 7,373 | $1.42 |
| Meredith Deborah JeanDirector | Jun 14, 2023 | Sell | 6,556 | $1.65 |
| Meredith Deborah JeanDirector | Jun 13, 2023 | Sell | 6,491 | $1.62 |
| Meredith Deborah JeanDirector | Jun 6, 2023 | Sell | 10,000 | $1.62 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Nov 28, 2025 | 13,818 | 1.0 | -31.7% |
| Nov 14, 2025 | 20,224 | 1.0 | +37.0% |
| Oct 31, 2025 | 14,760 | 1.0 | -7.1% |
| Oct 15, 2025 | 15,886 | 1.0 | -33.4% |
| Sep 30, 2025 | 23,846 | 1.0 | +102.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 18, 2026
- Shareholder voteDec 19, 2025
- Regulation FD disclosure · Other material eventDec 11, 2025
- Amended charter or bylaws · Regulation FD disclosureDec 8, 2025
- Results of operationsNov 13, 2025
- Director / officer change · Other material eventSep 11, 2025
- Results of operationsAug 14, 2025
- Other material eventAug 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 18, 2026
- 10-QFORM 10-QMay 15, 2026
- EFFECTApr 10, 2026
- CORRESPApr 8, 2026
- UPLOADApr 7, 2026
- S-3FORM S-3Apr 2, 2026
- 10-KFORM 10-KMar 20, 2026
- 8-KFORM 8-KDec 19, 2025
- 8-KFORM 8-KDec 11, 2025
- 8-KFORM 8-KDec 8, 2025
- 4FORM 4Nov 19, 2025
- 4FORM 4Nov 17, 2025
- 4FORM 4Nov 17, 2025
- SCHEDULE 13G/ANov 14, 2025
- SCHEDULE 13G/ANov 14, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.